Vivo Capital, LLC
CIK: 0001674712SEC EDGAR →
Portfolio Value
$1.5B
Holdings
47
As of
Q4 2025
New Positions
8
Closed Positions
3
Top 10 Holdings
| Rank | Stock | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Terns Pharmaceuticals Inc | 5,346,928 | $216.0M | 13.96% |
| 2 | Cidara Therapeutics, Inc. | 956,670 | $211.3M | 13.66% |
| 3 | Praxis Precision Medicines | 328,895 | $96.9M | 6.27% |
| 4 | Cogent Biosciences Inc | 2,398,993 | $85.2M | 5.51% |
| 5 | Trevi Therapeutics Inc | 5,094,668 | $63.8M | 4.12% |
| 6 | Avadel Pharmaceuticals PLC | 2,684,109 | $57.8M | 3.74% |
| 7 | Compass Therapeutics Inc | 9,545,466 | $51.3M | 3.31% |
| 8 | Dyne Therapeutics Inc | 2,614,960 | $51.1M | 3.31% |
| 9 | Abivax SA - ADR | 359,305 | $48.5M | 3.13% |
| 10 | DBV Technologies SA | 2,461,626 | $47.2M | 3.05% |
Quarterly Changes
New Positions (7)
Sector Breakdown
| Sector | # Holdings | Value | % |
|---|---|---|---|
| Healthcare | 45 | $1.3B | 84.0% |
| Unknown | 2 | $247.3M | 16.0% |